MRI-clinical correlations: More than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS?

Journal of the Neurological Sciences

Volumn 206, Issue 2, 2003, Pages 175-179

  Wayne Moore, G R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Magnetic resonance imaging; Multiple sclerosis; Pathology

Indexed keywords

BRAIN INJURY; CORRELATION ANALYSIS; DISEASE COURSE; HISTOPATHOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

EID: 0037441486     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00347-7     Document Type: Article

References (45)

1. Paty D.W., Oger J.J.F., Kastrukoff L.F., Hashimoto S.A., Hooge J.P., Eisen A.A.et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 38:1988;180-185.
2. McDonald W.I., Miller D.H., Barnes D. The pathological evolution of multiple sclerosis. Neuropathol. Appl. Neurobiol. 18:1992;319-334.
3. Fazekas F., Barkhof F., Filippi M., Grossman R.I., Li D.K.B., McDonald W.I.et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 53:1999;448-456.
4. 2 in rat tissues after biopsy and fixation. Magn. Reson. Imaging. 3:1985;245-250.
5. Györffy-Wagner Z., Englund E., Larsson E.M., Brun A., Cronqvist S., Persson B. Proton magnetic resonance relaxation times T1 and T2 related to post-mortem interval. An investigation on porcine brain tissue. Acta Radiol. Diagn. (Stockholm). 27:1986;115-118.
6. Nagara H., Inoue T., Koga T., Kitaguchi T., Tateishi J., Goto I. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J. Neurol. Sci. 81:1987;67-77.
7. Grafe M.R., Press G.A., Berthoty D.P., Hesselink J.R., Wiley C.A. Abnormalities of the brain in AIDS patients: correlation of postmortem MR findings with neuropathology. Am. J. Neuroradiol. 11:1990;905-911.
8. Unger E.C., Gado M.H., Fulling K.F., Littlefield J.L. Acute cerebral infarction in monkeys: an experimental study using MR imaging. Radiology. 162:1987;789-795.
9. Estes M.L., Rudick R.A., Barnett G.H., Ransohoff R.M. Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging. Arch Neurol. 47:1990;1299-1303.
10. Nesbit G.M., Forbes G.S., Scheithauer B.W., Okazaki H., Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology. 180:1991;467-474.
11. Stewart W.A., Hall L.D., Berry K., Churg A., Oger J., Hashimoto S.A.et al. Magnetic resonance imaging (MRI) in multiple sclerosis (MS): pathological correlation studies in eight cases. Neurology. 36(suppl. 1):1986;320. [abstract].
12. Ormerod I.E.C., Miller D.H., McDonald W.I., du Boulay E.P.G.H., Rudge P., Kendall B.E.et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. 110:1987;1579-1616.
13. Barnes D., Munro P.M.G., Youl B.D., Prineas J.W., McDonald W.I. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain. 114:1991;1271-1280.
14. Newcombe J., Hawkins C.P., Henderson C.L., Patel H.A., Woodroofe M.N., Hayes G.M.et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed central nervous system tissue. Brain. 114:1991;1013-1023.
15. van Walderveen M.A.A., Kamphorst W., Scheltens P., van Waesberghe J.H.T.M., Ravid R., Valk J.et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 50:1998;1282-1288.
16. Katz D., Taubenberger J.K., Cannella B., McFarlin D.E., Raine C.S., McFarland H.F. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann. Neurol. 34:1993;661-669.
17. Ludwin S.K., Henry J.M., McFarland H. Vascular proliferation and angiogenesis in multiple sclerosis: clinical and pathogenetic considerations. MS 2000. Symposium on conquering multiple sclerosis: research in Canada in the new millennium. 2000;Multiple Sclerosis Society of Canada. Abstract.
18. Arnold D.L., Matthews P.M., Francis G.S., O'Connor J., Antel J.P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31:1992;235-241.
19. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L. Axonal transection in the lesions of multiple sclerosis. N. Eng. J. Med. 338:1998;278-285.
20. Wolinsky J.S., Narayana P.A., Fenstermacher M.J. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology. 40:1990;1764-1769.
21. Filippi M. Magnetization transfer imaging to monitor the evolution of individual multiple sclerosis lesions. Neurology. 53(suppl. 3):1999;S18-S22.
22. Brochet B., Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology. 53(suppl. 3):1999;S12-S17.
23. Ropele S., Strasser-Fuchs S., Augustin M., Stollberger R., Enzinger C., Hartung H.-P.et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. Am. J. Neuroradiol. 21:2000;1885-1891.
24. Filippi M., Inglese M. Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis. J. Neurol. Sci. 186(suppl. 1):2001;S37-S43.
25. MacKay A., Whittall K., Adler J., Li D., Paty D., Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med. 31:1994;673-677.
26. Moore G.R.W., Leung E., MacKay A.L., Vavasour I.M., Whittall K.P., Cover K.S.et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology. 55:2000;1506-1510.
27. Brück W., Bitsch A., Kolenda H., Brück Y., Stiefel M., Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 42:1997;783-793.
28. Gharagozloo A.M., Poe L.B., Collins G.H. Antemortem diagnosis of Baló concentric sclerosis: correlative MR imaging and pathologic features. Radiology. 191:1994;817-819.
29. Seitelberger F. Histochemistry of demyelinating diseases proper including allergic encephalomyelitis and Pelizaeus-Merzbacher's disease. Cuming J.N. Modern scientific aspects of neurology. 1960;337-344 Edward Arnold, London.
30. Allen I.V., McKeown S.R. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J. Neurol. Sci. 41:1979;81-91.
31. Allen I.V., Glover G., Anderson R. Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). Acta Neuropathol. Suppl. (Berlin). 7:1981;176-178.
32. Arstila A.U., Riekkinen P., Rinne U.K., Laitinen L. Studies on the pathogenesis of multiple sclerosis: participation of lysosomes on demyelination in the central nervous system white matter outside plaques. Eur. Neurol. 9:1973;1-20.
33. Evangelou N., Esiri M.M., Smith S., Palace J., Mathews P.M. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann. Neurol. 47:2000;391-395.
34. Evangelou N., Konz D., Esiri M.M., Smith S., Palace J., Mathews P.M. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain. 123:2000;1845-1849.
35. Filippi M., Tortorella C., Bozzali M. Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance technique. Mult. Scler. 5:1999;273-282.
36. Karlik S.J., Erskine M., Lee D., Rice G. Comparison of 1.5 and 4.0 Tesla magnetic resonance imaging examinations of patients with multiple sclerosis. 123rd annual meeting of the American Neurological Society. 1998;69. Abstract.
37. Barbosa S., Blumhardt L.D., Roberts N., Lock T., Edwards R.H. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn. Reson. Imaging. 12:1994;33-42.
38. De Stefano N., Matthews P.M., Antel J.P., Preul M., Francis G., Arnold D.L. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann. Neurol. 38:1995;901-909.
39. Filippi M., Campi A., Dousset V., Baratti C., Martinelli V., Canal N.et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology. 45:1995;478-482.
40. Filippi M., Rocca M.A., Martino G., Horsfield M.A., Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol. 43:1998;809-814.
41. Willoughby E.W., Grochowski E., Li D.K.B., Oger J., Kastrukoff L.F., Paty D.W. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann. Neurol. 25:1989;43-49.
42. Zhao G., Li D.K.B., Wang X., Cheng Y., Paty D.W. MRI dirty-appearing white matter in MS. Neurology. 54(suppl. 3):2000;A121. [abstract].
43. 2 , MT, water content and myelin water content. Mult. Scler. 7(suppl. 1):2001;S90. [abstract].
44. Stewart W.A., Hall L.D., Berry K., Paty D.W. Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet. 2:1984;412.
45. Bitsch A., Kuhlmann T., Stadelmann C., Lassmann H., Lucchinetti C., Brück W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann. Neurol. 49:2001;793-796.